California Public Employees Retirement System Dyne Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$15.94 - $22.33 $456,473 - $639,464	-28,637 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$14.0 - $29.3 $37,968 - $79,461	-2,712 Reduced 8.65%	28,637 $445,000
Q4 2020 Feb 02, 2021	BUY	$16.81 - $23.94 $526,976 - $750,495	31,349 New	31,349 $658,000

Others Institutions Holding DYN

# of Institutions

210

Shares Held

102M

Call Options Held

234K

Put Options Held

238K

Atlas Venture Life Science Advisors, LLC

8.02M
Shares

$241 Million
35.54% of portfolio
Black Rock Inc. New York, NY

7.39M
Shares

$222 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.86M
Shares

$206 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

6.82M
Shares

$204 Million
3.9% of portfolio
Janus Henderson Group PLC London, X0

6.81M
Shares

$204 Million
0.13% of portfolio

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.55B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account